National News: Ocugen files Covaxin IND application with USFDA, seeks nod for Phase-3 trial in US | India News – Rashtra News

Ocugen files Covaxin IND application with USFDA, seeks nod for Phase-3 trial in US | India News - Rashtra News : Rashtra News #Ocugen #files #Covaxin #IND #application #USFDA #seeks #nod #Phase3 #trial #India #News #Times #India HYDERABAD: Ocugen Inc, Bharat Biotech’s US and Canada partner for indigenously developed Covid-19 vaccine Covaxin, has submitted an

Related Keywords

India ,United States ,Hyderabad ,Andhra Pradesh ,Canada ,Bharat ,American ,Shankar Musunuri ,Ocugen Inc ,Drug Administration ,India News ,Rashtra News ,Bharat Biotech ,Investigational New Drug ,News Source ,Application ,Breaking News ,Covaxin ,Covid 19 ,Fda ,Files ,Google News ,Wind ,India News Today ,National ,News ,Nod ,Ocugen ,Phase3 ,Rashtra ,Seeks ,Today News ,Trial ,Usfda ,